The Benefit/Risk ratio for novel anticoagulants

Anticoagulation therapy can increase the risk of bleeding. Therefore, it is not always clear whether the benefit of an anticoagulant therapy—for example, reducing thromboembolic events—is sufficient to outweigh the increased risk of bleeding. To balance the benefits against the risks, physicians must consider which negative events can be reduced and which bleeding events are likely to be increased.